Table 3 Variables associated with QFT-GIT reversion
From: Serial interferon-gamma release assays during treatment of active tuberculosis in young adults
Number (%) | Number with reversion (%) | Odds ratio (95%CI) | Pvalue | |
|---|---|---|---|---|
Cavity | ||||
Present | 18 (31.6) | 6 (33.3) | 1.00 (reference) | 0.85 |
Absent | 39 (68.4) | 12 (30.8) | 1.13 (0.34-3.71) | |
Lesion extent | ||||
> one lobe | 28 (49.1) | 8 (27.6) | 1.00 (reference) | 0.45 |
one lobe | 29 (50.9) | 10 (35.7) | 1.55 (0.50-4.77) | |
Pleural effusion | ||||
Absent | 43 (75.4) | 11 (25.6) | 1.00 (reference) | 0.10 |
Present | 14 (24.6) | 7 (50.0) | 2.91 (0.83-10.17) | |
CRP | ||||
< 3 mg/dl | 41 (73.3) | 10 (24.4) | 1.00 (reference) | 0.046 |
≥ 3 mg/dl | 15 (26.8) | 8 (53.3) | 3.54 (1.03-12.24) | |
Body temperature* | ||||
< 38.3°C | 44 (76.8) | 11 (25.6) | 1.00 (reference) | 0.056 |
≥ 38.3 °C | 13 (23.2) | 7 (53.8) | 3.50 (0.97-12.67) | |
Baseline QFT-GIT | ||||
decrease by 1 IU/ml | 57 (100) | 18 (31.6) | 1.24 (1.03-1.49) | 0.03 |